News & Events | FDA - U.S. Food and Drug Administration
WEBFDA news releases, media contacts, speeches, meetings and workshops, and other ways that FDA engages with the public.
FDA Releases Two Discussion Papers to Spur Conversation about ...
WEBTo address these concerns, the FDA has released a discussion paper, “Using Artificial Intelligence and Machine Learning in the Development of Drug and Biological Products.”
FDA blindsided as Trump Admin cripples agency on its way out
WEBJan 15, 2021 · Perhaps the most dramatic meddling came on Monday, when FDA officials were blindsided as the agency cycled through three different top lawyers. FDA’s Chief Counsel, Stacy Cline Amin—a Trump...
FDA Newsroom | FDA - U.S. Food and Drug Administration
WEBJan 4, 2023 · The latest news and events at the U.S. Food and Drug Administration (FDA) and resources for journalists.
Food and Drug Administration - The New York Times
WEBNews about Food and Drug Administration, including commentary and archival articles published in The New York Times.
A Cutting-Edge Cancer Treatment May Cause Cancer. The FDA Is ... - WIRED
WEBNov 29, 2023 · CAR-T cell therapy harnesses the immune system to attack blood cancers. Six years after approving the first treatment, the FDA is investigating whether it can give rise to secondary cancers.
Do cutting-edge CAR-T-cell therapies cause cancer? What the
WEBApr 30, 2024 · The US Food and Drug Administration (FDA) said it was looking at whether a strategy that involves engineering a person’s immune cells to kill cancer was leading to new malignancies in people who...
Exclusive: FDA enforcement actions plummet under Trump
WEBJul 2, 2019 · Food and Drug Administration enforcement actions are dropping under President Donald Trump. The number of warning letters and injunctions (through May 22) and Official Action Indicated (OAI) reports (through April 22) fell steeply from the equivalent periods before his inauguration.
FDA staff focus on ‘off-target’ risk in review of Vertex, CRISPR …
WEBOct 27, 2023 · Food and Drug Administration scientists are scrutinizing whether an experimental gene editing therapy for sickle cell disease makes unwanted changes to DNA as part of the agency’s closely watched review of the CRISPR-based treatment.
Search for FDA Guidance Documents
WEBThe table below lists all official FDA Guidance Documents and other regulatory guidance. You can search for documents using key words, and you can narrow or filter your results by product, date...
- Some results have been removed